Who owns that blood? Recontacting donors with results from genetic testing after allogeneic hematopoietic cell transplantation

Documenti analoghi

• Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation
  di: Konradin F. Müskens, et al.
  Pubblicazione: (2024)
• HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
  di: Sophie Le Grand, et al.
  Pubblicazione: (2025)
• Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemia
  di: Marion Larue, et al.
  Pubblicazione: (2024)
• Time‐restricted versus standard‐duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON‐96 trial
  di: Annoek E. C. Broers, et al.
  Pubblicazione: (2024)
• Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
  di: Baptiste Le Calvez, et al.
  Pubblicazione: (2024)